Gerlinde Egerer
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments 26
- Genetics top 1%
- Oncology top 2%
- Neutropenia and Cancer Infections 26
- Vascular Tumors and Angiosarcomas 23
- Cancer Treatment and Pharmacology 15
-
- Lymphoma Diagnosis and Treatment 19
- Neurology top 2%
-
- Sarcoma Diagnosis and Treatment 45
-
- Antifungal resistance and susceptibility 18
-
- Fungal Infections and Studies 15
- Co-authors
- Anthony D. HoHartmut GoldschmidtKai NebenThomas MoehlerHelmut K. SeitzAxel BennerBernd KasperRainer Haas
- Cited by
- HematologyGeneticsOncology
- Journals
- Journal of Clinical Oncology (10 papers)Bone Marrow Transplantation (9 papers)Annals of Hematology (8 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Gerlinde Egerer
175 papers receiving 4.5k citations
Peers
Comparison fields: 5 of 129
- Hematology 1.2k
- Genetics 725
- Oncology 1.4k
- Pathology and Forensic Medicine 887
- Neurology 704
Countries citing papers authored by Gerlinde Egerer
This map shows the geographic impact of Gerlinde Egerer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerlinde Egerer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerlinde Egerer more than expected).
Fields of papers citing papers by Gerlinde Egerer
This network shows the impact of papers produced by Gerlinde Egerer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerlinde Egerer. The network helps show where Gerlinde Egerer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gerlinde Egerer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 5 | |
| 3 | 2021 | 5 | |
| 4 | 2019 | 4 | |
| 5 | 2017 | 1 | |
| 6 | 2017 | 14 | |
| 7 | 2016 | 32 | |
| 8 | 2013 | 2 | |
| 9 | 2012 | 40 | |
| 10 | 2010 | 255 | |
| 11 | 2009 | 82 | |
| 12 | 2006 | 17 | |
| 13 | 2003 | 22 | |
| 14 | 2002 | 8 | |
| 15 | 2001 | 56 | |
| 16 | 2000 | 7 | |
| 17 | 2000 | 101 | |
| 18 | 1999 | 15 | |
| 19 | 1998 | 7 | |
| 20 | 1993 | 143 |
About Gerlinde Egerer
Gerlinde Egerer is a scholar working on Hematology, Oncology and Genetics, having authored 181 papers that have together received 4.6k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (45 papers), Neutropenia and Cancer Infections (26 papers), Multiple Myeloma Research and Treatments (26 papers), Vascular Tumors and Angiosarcomas (23 papers), Lymphoma Diagnosis and Treatment (19 papers), Antifungal resistance and susceptibility (18 papers), Cancer Treatment and Pharmacology (15 papers) and Fungal Infections and Studies (15 papers). The work is most often cited by research in Hematology (1.2k citations), Genetics (725 citations) and Oncology (1.4k citations). Gerlinde Egerer has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Anthony D. Ho, Hartmut Goldschmidt, Kai Neben, Thomas Moehler, Helmut K. Seitz, Axel Benner, Bernd Kasper, Rainer Haas, Jens Hillengaß and Gunhild Mechtersheimer. Their work appears in journals such as Journal of Clinical Oncology, Bone Marrow Transplantation, Annals of Hematology, Blood and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.